Notably, Lira significantly regulated ECM-receptor interactions, particularly by decreasing LAMC1 and COL4A2 protein levels, suggesting a potential mechanism for ameliorating hepatic fibrosis (Fig. 5C). This evidence concerns the gene COL4A2 and Hepatic fibrosis.